ASPI vs BSIN vs LIN Stock Comparison

ASP Isotopes, Big Sky Industrial and Linde Prices as of Oct 23, 2026 Peers: Industry group
ASPI ASP Isotopes Inc.
$1.95 -35.2% 1M -79.6% 1Y
Market cap
$248.50M
P/E
–
Revenue (TTM)
$30.85M
Div. yield
–
Specialty Chemicals Basic Materials
1 win
BSIN Big Sky Industrial Inc.
$1.55 +5.4% 1M +26.0% 1Y
Market cap
$82.78M
P/E
–
Revenue (TTM)
$6.87M
Div. yield
–
Oil and Gas Exploration and Production Energy
2 wins
LIN Linde Plc
$508.83 +8.3% 1M +13.1% 1Y
Market cap
$234.80B
P/E
32.4x
Revenue (TTM)
$35.45B
Div. yield
0.01%
Industrial Gases Basic Materials
6 wins

Head to Head

9 decided of 12

Linde leads on 6 of the 12 questions below (Linde 6, Big Sky Industrial 2, ASP Isotopes 1). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionASPIBSINLINLeader
Larger companyMarket capitalisation $248.50M $82.78M $234.80B LIN
Cheaper on earningsLower P/E, profitable companies only -2.1x -7.8x 32.4x –
Cheaper on forward earningsLower price / next fiscal year consensus EPS — — 30.4x –
Faster revenue growthRevenue growth, trailing twelve months +573.4% -48.7% +6.6% ASPI
More profitableNet margin, trailing twelve months -380.3% -155.3% 20.4% LIN
Better return on capitalReturn on invested capital -28.6% -25.6% 10.8% LIN
Less leveragedLower net debt / EBITDA 2.1x 0.2x 1.8x BSIN
Higher dividend yieldTrailing dividend yield 0.00% 0.00% 0.01% –
Better 1-year returnPrice return, last 12 months -79.6% +26.0% +13.1% BSIN
Better 5-year returnAnnualised price return, 5 years — -16.5%/yr +10.1%/yr LIN
Less volatileAnnualised volatility, 1 year 98.8% 74.8% 19.2% LIN
Higher overall scoreMean of the five percentile scores vs peers 26/100 24/100 59/100 LIN

Percentile Scorecard

ASPIBSINLIN

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisASPIBSINLIN
Valuation 9 #86 of 94 10 #89 of 99 20 #75 of 94
Growth 19 #75 of 92 20 #78 of 97 66 #32 of 92
Profitability 8 #82 of 89 8 #88 of 96 94 #6 of 89
Financial Health 69 #31 of 97 71 #30 of 102 52 #47 of 97
Shareholder Returns – 8 #70 of 76 64 #26 of 70
Overall 26 24 59
  • ASPI ranked among 99 companies in Chemicals
  • BSIN ranked among 103 companies in Oil and Gas Upstream
  • LIN ranked among 99 companies in Chemicals

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodASPIBSINLINSPY
1 month -35.2%+5.4%+8.3% -1.0%
3 months -49.6%+21.1%-0.7% +2.9%
6 months -63.6%+66.7%-0.3% +6.4%
Year to date -63.6%+68.5%+19.3% +11.4%
1 year -79.6%+26.0%+13.1% +13.1%
3 years +77.3%+16.5%+38.5% +79.4%
3 years, per year +21.0%+5.2%+11.5% +21.5%
5 years —-59.4%+62.0% +67.7%
5 years, per year —-16.5%+10.1% +10.9%
10 years —-91.1%+324.4% +255.2%
10 years, per year —-21.5%+15.6% +13.5%

Risk

MeasureASPIBSINLINSPY
Volatility, 1Y 98.8%74.8%19.2% 12.7%
Downside volatility, 1Y 99.5%76.0%19.5% 12.7%
Beta vs S&P 500, 1Y 3.88-0.680.05 1.00
Return / volatility, 1Y -0.810.350.68 1.03
Max drawdown, 5Y -88.6%-91.2%-23.7% -25.4%
From 52-week high -81.9%-6.1%-6.9% -2.5%
52-week high $10.76$1.65$546.64 $779.14
52-week low $1.95$0.69$389.38 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleASPIBSINLIN
P/E now vs peer median -2.0xmedian 21.5x -7.6xmedian 13.1x 32.5xmedian 21.5x
P/S now vs peer median 8.2xmedian 1.4x 11.8xmedian 2.0x 6.6xmedian 1.4x
EV/EBITDA now vs peer median -0.6xmedian 12.4x -10.0xmedian 5.7x 19.5xmedian 12.4x
P/FCF now vs peer median -3.0xmedian 15.5x -18.7xmedian 11.1x 47.1xmedian 15.5x
P/B now vs peer median 0.9xmedian 1.6x 2.2xmedian 1.5x 5.8xmedian 1.6x
PEG now vs peer median 0.05median 1.70 0.06median 2.24 3.07median 1.70

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsASPIBSINLIN
Revenue $30.85M $6.87M $35.45B
Gross profit $5.65M – $17.14B
Operating income -$99.07M -$10.56M $9.38B
Net income -$117.34M -$10.67M $7.26B
Free cash flow -$83.58M -$4.35M $4.98B
R&D $22.04M $406.00K $146.00M
EPS (diluted) $-0.96 $-0.20 $15.59
Cash & equivalents $219.60M $5.99M $4.90B
Total debt $59.77M $9.50M $28.01B
Shares (diluted) 122.72M 52.39M 464.52M
Enterprise value -$738.21M $63.76M $216.38B

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricASPIBSINLIN
P/E -2.0x -7.6x 32.5x
P/FCF -3.0x -18.7x 47.1x
P/Operating cash flow -3.7x -19.1x 22.4x
P/S 8.2x 11.8x 6.6x
P/B 0.9x 2.2x 5.8x
P/Tangible book 0.9x 2.2x 8.1x
EV/EBITDA -0.6x -10.0x 19.5x
EV/EBIT -0.6x -7.6x 27.5x
EV/Revenue 1.9x 11.6x 7.3x
EV/FCF -0.7x -18.3x 51.8x
EV/Operating cash flow -0.9x -18.7x 24.6x
PEG (3Y EPS CAGR) 0.05 0.06 3.07

Growth

14 metrics
MetricASPIBSINLIN
Revenue growth (1Y) 573.4% -48.7% 6.6%
Revenue CAGR (3Y) 2,420% -43.7% 2.3%
Gross profit growth (1Y) 214.3% – 6.4%
Gross profit CAGR (3Y) – – 5.4%
Operating income growth (1Y) -200.2% 58.2% 5.4%
Operating income CAGR (3Y) -105.1% -32.3% 9.0%
Net income growth (1Y) -17.1% 54.2% 8.1%
Net income CAGR (3Y) -119.1% -93.9% 8.2%
EPS growth (1Y) 30.3% 71.4% 10.0%
EPS CAGR (3Y) -37.1% -132.5% 10.6%
Operating cash flow growth (1Y) -244.7% -128.5% 5.8%
Operating cash flow CAGR (3Y) -151.6% -35.6% 6.1%
Free cash flow growth (1Y) -182.5% 0.1% -1.9%
Free cash flow CAGR (3Y) -123.3% 29.3% -2.7%

Profitability

14 metrics
MetricASPIBSINLIN
Gross margin 18.3% – 48.3%
EBITDA margin -303.3% -116.0% 37.2%
Operating margin -321.1% -153.7% 26.5%
Pretax margin -443.4% -155.2% 26.4%
Net margin -380.3% -155.3% 20.4%
FCF margin -270.9% -63.4% 14.0%
Operating cash flow margin -219.8% -62.1% 29.6%
Return on equity -40.9% -28.3% 18.3%
Return on assets -20.2% -19.2% 8.4%
Return on invested capital -28.6% -25.6% 10.8%
Return on capital employed -19.4% -21.5% 13.2%
Asset turnover 0.1x 0.1x 0.4x
Cash conversion (OCF / net income) 0.6x 0.4x 1.4x
Stock comp / revenue 60.5% 27.7% 0.4%

Financial Health

11 metrics
MetricASPIBSINLIN
Debt / assets 10.4% 8.0% 31.7%
Debt / equity 0.2x 0.1x 0.7x
Net debt / EBITDA 2.1x 0.2x 1.8x
Debt / FCF -0.7x -1.0x 5.6x
Liabilities / assets 52.0% 33.8% 54.0%
Equity / assets 48.0% 66.2% 46.0%
Interest coverage -25.3x – 37.4x
Current ratio 3.9x 1.2x 0.9x
Quick ratio 3.7x 1.0x 0.7x
Cash ratio 3.6x 0.9x 0.3x
Altman Z-score -0.25 -3.33 3.97

Shareholder Returns

7 metrics
MetricASPIBSINLIN
Dividend yield – – 1.2%
Net buyback yield – -21.1% 1.7%
Shareholder yield – -21.1% 3.0%
Payout ratio (earnings) – – 39.7%
Payout ratio (FCF) – – 57.8%
Dividend growth (1Y) – – 5.3%
Dividend CAGR (3Y) – – 6.1%

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusASPIBSINLIN
Forward P/E – – 30.4xFY2026
EPS, next fiscal year $-0.45FY2026 $-0.21FY2026 $16.76FY2026
EPS growth, next FY – – +1.9%FY2026
EPS growth, the year after – – +14.1%
Revenue, next fiscal year $24.34MFY2026 $6.79MFY2026 $38.84BFY2026
Revenue growth, next FY +2.0%FY2026 -7.6%FY2026 +14.3%FY2026
Revenue growth, the year after +189.0% +149.4% -4.2%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersASPIBSINLIN
Held by institutions 50.3% 14.7% 85.2%
Institutions holding 186 39 2,321
Change in shares held, QoQ +3.3% +63.3% +4.2%
Institutions buying 113 28 1,213
Institutions selling 53 4 764
Buyers to sellers 2.13 7.00 1.59

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

ASPIBSINLIN
ASPI 1.00 0.05 -0.02
BSIN 0.05 1.00 -0.04
LIN -0.02 -0.04 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, ASPI, BSIN and LIN?

Linde (LIN) is the largest by market capitalisation: ASP Isotopes (ASPI) $248.50M, Big Sky Industrial (BSIN) $82.78M, Linde (LIN) $234.80B.

Which company is growing faster?

ASP Isotopes (ASPI) grew revenue fastest over the trailing twelve months: ASP Isotopes (ASPI) +573.4%, Big Sky Industrial (BSIN) -48.7%, Linde (LIN) +6.6%.

Which company is more profitable?

Linde (LIN) has the highest net margin (ASP Isotopes (ASPI) -380.3%, Big Sky Industrial (BSIN) -155.3%, Linde (LIN) 20.4%). On return on invested capital, Linde (LIN) leads (ASP Isotopes (ASPI) -28.6%, Big Sky Industrial (BSIN) -25.6%, Linde (LIN) 10.8%).

Which stock has performed better?

Over the past year Big Sky Industrial (BSIN) returned the most: ASP Isotopes (ASPI) -79.6%, Big Sky Industrial (BSIN) +26.0%, Linde (LIN) +13.1%. Over five years, Linde (LIN) compounded fastest (Big Sky Industrial (BSIN) -16.5%/yr, Linde (LIN) +10.1%/yr). Returns are price only, before dividends.

Which pays a higher dividend?

Only one of these companies pays a dividend: ASP Isotopes (ASPI) 0.00%, Big Sky Industrial (BSIN) 0.00%, Linde (LIN) 0.01%. ASP Isotopes (ASPI) and Big Sky Industrial (BSIN) pays no regular dividend.

Which stock is riskier?

By one-year price volatility, Linde (LIN) has been the steadiest (ASP Isotopes (ASPI) 98.8%, Big Sky Industrial (BSIN) 74.8%, Linde (LIN) 19.2%). Volatility measures how widely the price swings, not the risk of the business.

Which is the better stock, ASPI, BSIN and LIN?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Linde (LIN) leads on 6. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.